Loading…
20,252 grants found
Showing 941 – 960 of 20,252 grants
PROJECT SUMMARY Prostate cancer (PCa) is the most common cancer among men. Radiation therapy is an integral part of the standard of care for the treatment of PCa. Local recurrences...
PROJECT SUMMARY Cancer treatment has been transformed by a class of drugs, that includes Keytruda and Opdivo, that enables the immune system to recognize and selectively kill cance...
PROJECT SUMMARY While there have been tremendous advances in the treatment of estrogen receptor-positive (ER+) breast cancer, late-stage ER+ metastatic breast cancer (MBC) has very...
Project Summary/Abstract Transcription growth factor beta (TGFβ) is a pleiotropic cytokine with a significant role in creating an immunosuppressive tumor microenvironment. High lev...
HMGA1 Chromatin Regulators in Pancreatic Carcinogenesis ABSTRACT Background: We propose to elucidate mechanisms mediated by High Mobility Group A1 (HMGA1) chromatin regulators in p...
ABSTRACTThis application validates a minimally invasive, multi-stage artificial intelligence (AI)-based cytologic, histologic andepigenetic biomarker to identify oral premalignant...
ABSTRACT The efficacy of cell-based immunotherapies in treating solid tumors is hampered due to challenges pertaining to infiltration, function, and persistence of CD8+ effector T...
First line platinum-based chemotherapies kill cancer cells through formation of bulky DNA adducts, however,these adducts also form in healthy tissues leading to side effects that s...
PROJECT SUMMARY/ABSTRACT Chronic pain is a common symptom that affects 30-40% of cancer survivors, diminishing their quality of life, impairing physical functions, and increasing h...
Project Summary/Abstract The objective of the project is to develop the world-first X-ray dual-energy cone-beam microCT (DECB µCT) dedicated to intraoperative imaging of lumpectomy...
Project Summary/Abstract Despite the progress in the treatment of advanced melanoma brought by the approval and use of immune checkpoint inhibitors (ICIs), most patients are resist...
PROJECT SUMMARY/ABSTRACT Rural-serving primary care clinics in our Colorado Implementation Science Center in Cancer Control (COISC3) seek to address inequities in behavioral cancer...
SUMMARY Non-small cell lung cancer (NSCLC) remains the deadliest cancer, and novel therapeutic strategies are needed to improve treatment outcomes of patients with this disease. FT...
ABSTRACT Mutations in the BRAF protein kinase are key drivers of melanoma, thyroid cancer, and colon cancer. Existing drugs, like vemurafenib, that target the most common BRAF muta...
Pancreatic cancer (PanCan) is notorious for its resistance to therapy including immunotherapy, which is largely contributed by a suppressive tumor microenvironment. Targeting molec...
PROJECT SUMMARY Osteosarcoma (OS) metastasis is the leading driver of mortality, but there are no therapies tailored to metastatic disease. Despite the development of numerous trea...
Project Summary Atypical teratoid rhabdoid tumors (ATRTs) are aggressive pediatric brain cancers that lack standardized treatment regimens. After radiotherapy treatments, survivors...
Project Summary/Abstract Malignant tumors escape immune surveillance by evading, suppressing, or distorting immune function. The recent success of immune checkpoint blockade therap...
Title: Development of novel nanotherapeutics to overcome therapy resistance using canine brain tumor as a spontaneous model Project Summary/Abstract High-grade gliomas (HGGs), incl...
PROJECT SUMMARY/ABSTRACT Cancer-associated chromosomal abnormalities frequently arise through punctuated episodes of genomic instability. This is exemplified by chromothripsis, the...